Home » Topics » Regulatory

Regulatory
RSS

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

U.K. approval for Edronax

April 21, 1997

Imitrex Nasal Spray introduced in Canada

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Generic minoxidil receives FDA approval

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...